Independent management consultant working directly with senior leadership teams at selected innovative pharmaceutical and medical technology firms. Particular focus on corporate strategy and board/leadership team facilitation. Recent assignments include:- Working with the CEO and leadership team of a rapidly growing biopharma firm helping them define the organization and processes to enable rapid scale up and successful late stage development and commercialization of multiple assets- Defining new business processes to improve the efficiency and effectiveness of new product development in a mid sized biotech. Helping set the organization up to grow and expand across multiple sites- Assisting a rapidly growing medical aesthetics company identify long term strategic options to maximize shareholder value. Worked directly with senior management team to evaluate a broad range of potential paths forward and use financial and other assessments to recommend an optimal path- Helping a leading US based specialty biopharma evaluate options to leverage it's industry leading commercial position in the Chinese pharma market. Evaluated a broad range of potential global licensing and M&A options and worked with senior leadership and board to recommend optimal future approach and necessary organizational capabilities

Member of board of directors for an innovative arts organization dedicated to perpetuating the uniquely American genre of symphonic jazz through its commissioning program, and inspiring the next generations of listeners through its “Music in the Schools” program, and Community Outreach Program. Helping SJO grow and expand its impact in Southern California and beyond. Currently helping drive a project to raise funds to celebrate the legacy of George Duke and record one of his compositions with the SJO.

Member of board of directors for a leading fast growing international development NGO with annual global program expenditures of $40M. Served as Chairman from 2008-2012. Led the board in establishing full committee structure and appropriate governance. Oversaw merger of RI with Enterprise Works/VITA. Helped organization define strategy and processes to enable doubling in size during my tenure on the board.

Core member of BCG global healthcare team (2003-2012). Built and drove deep client relationships with personal direct responsibility for driving $5-10M of consulting business each year. Worked extensively in biotech, big pharma, and specialty pharma R&D as well as more broadly across the healthcare value chain. Focus in new product development, pricing and commercialization. Assisted top executives in shaping business processes and organizational structures to enable innovation. Deep experience in key therapeutic areas including oncology, diabetes, dermatology and immunology. Head of BCG West Coast Healthcare Business (2010-2012). Headed BCG healthcare team across LA and SF offices. Drove 40% increase in business with West Coast clients. Established network with leading executives in CA. Published extensively on performance of the FDA and implications for US biotech and medtech firms. Head of Worldwide Marketing for BCG Healthcare practice (2009-2012). As a member of BCGs worldwide healthcare leadership team built BCGs global brand in healthcare leading development of new digital platform and development and dissemination of new intellectual property across print (NRDD, In Vivo, Pharma Executive), conferences and digital media.Co-leader BCG Worldwide BioPharma R&D Business (2006-2009). Helped drive and develop unique position in working with leading R&D executives and BCG worldwide team. Lead author for industry leading multi-year study of BioPharma licensing.

Led consulting assignments for pharmaceutical, biotech, medtech and payer clients in the US, Europe and Asia. Responsible for leading key elements of major post-merger integrations for top US and European based pharma companies. Helped define the end-to-end new product development and commercialization process for a top-US biotech. Defined new European commercial structure for a leading biotech. Led major PhRMA study on impact of price controls on the drug.

Led consulting assignments for a top UK clearing bank. Worked in retail banking, corporate finance and insurance subsidiaries. Helped drive major strategy and reengineering projects.